Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.
Open Access
- 1 December 1983
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 42 (6), 677-679
- https://doi.org/10.1136/ard.42.6.677
Abstract
Leukotriene B4 (LTB4), generated from arachidonic acid following lipoxygenase activity by a variety of inflammatory leucocytes, has been shown to be present in synovial fluid from patients with active rheumatoid arthritis. It does not persist as such, being converted to less active metabolites. The role of LTB4 as one of the natural mediators of inflammation is discussed.This publication has 8 references indexed in Scilit:
- Leukotriene B4 in synovial fluidJournal of Pharmacy and Pharmacology, 1982
- Leukotriene B4: An inflammatory mediator In vivoProstaglandins, 1981
- Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytesFEBS Letters, 1981
- Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.Journal of Clinical Investigation, 1980
- Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silicaProstaglandins, 1980
- Aggregation of rat polymorphonuclear leucocytes in vitroJournal of Pharmacy and Pharmacology, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- Arachidonic acid metabolism in polymorphonuclear leukocytesProceedings of the National Academy of Sciences, 1979